ANI Pharmaceuticals Inc
NASDAQ:ANIP
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Price:
76.435
USD
0.63%
Market Cap:
$1.7B
Relative Value
The Relative Value of one
ANIP
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 76.435 USD,
ANI Pharmaceuticals Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ANIP Relative Value
HIDDEN
Multiples Across Competitors
ANIP Competitors Multiples
ANI Pharmaceuticals Inc Competitors
ANI Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
ANI Pharmaceuticals Inc
NASDAQ:ANIP
|
1.7B USD | 2.1 | 49.9 | 11.8 | 25.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
943B USD | 14.5 | 45.7 | 30.8 | 32.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
582.6B USD | 6.2 | 21.8 | 15.1 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
262.8B CHF | 4.3 | 20.4 | 12 | 13.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.9B CHF | 5.3 | 21.5 | 13.3 | 17.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
223.2B GBP | 5.1 | 29.2 | 16.2 | 22.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288.4B USD | 4.4 | 15.8 | 9.8 | 12 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.9 | 8 | 9.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.3B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.2B USD | 2.5 | 17.1 | 7.2 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
